U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07096739) titled 'Tolerance of a High Protein Nutrition Shake in Individuals With GLP-1' on July 24.
Brief Summary: Determine if consuming a high protein nutrition shake reduces gastrointestinal symptoms associated with semaglutide injections.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
GLP-1 Concentration
Intervention:
DIETARY_SUPPLEMENT: High protein shake
Subjects in this study will consume the study product for 1 week. Participants will record GI symptoms over the past 24h on 3 days during the week prior to the intervention, and on days 3, 5, and 7 during the intervention. On the first day, overnight fasted participants ...